It was shown that treatment with non selective agonists β-AR (isoproterenol) and selective agonists of β1-AR (denopamine), β2-AR (formoterol and clenbuterol) and β3-AR (BRL37344) reduced ventricular arrhythmias and infarct size in laboratory animals submitted to cardiac I/R injury [67,68,69]. Here, ADRB2 is linked to Ventricular arrhythmia.